Sigma-Aldrich acquires Cerilliant

Monday, 10 January, 2011

Sigma-Aldrich has acquired all outstanding shares of Cerilliant of Round Rock, Texas to strengthen the company’s analytical chemistry product portfolio and to continue to deliver on its strategic growth plans.

Cerilliant, a supplier of high-quality reference standards and materials, provides products that support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic and clinical toxicology markets.

The company expects this acquisition to be neutral to mildly accretive to earnings per share in 2011. Cerilliant has been a portfolio company of Argenta Partners of Dallas, Texas, for the past 10 years.

Cerilliant brings to Sigma-Aldrich around 2800 products and 30 years of expertise in the design, development, synthesis, characterisation and packaging of analytical standards, calibrators, controls and certified reference materials that are used in a wide range of analytical applications.

Related News

Optics11 Life appoints Jacquelien ten Dam as CEO

Optics11 Life plans to accelerate its commercial growth in key markets while building strategic...

Epilepsy pioneer elected President of Aust Academy of Science

Laureate Professor Sam Berkovic — one of the world's most respected neurologists...

CSIRO announces 300+ job cuts as part of restructure

CSIRO will need to reduce roles in its Research Units by 300–350 full-time equivalent staff...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd